… We assumed that gefitinib and erlotinib in the experimental … in this meta-analysis of gefitinib
and erlotinib as most of the … significantly differ between gefitinib or erlotinib vs chemotherapy …

… The demographic data of these 716 patients is shown in Table 1. 302 … all patients according
to different lines of gefitinib or erlotinib. The disparities of choices on gefitinib or erlotinib (…

… All medical claims data in the NHI database of every patient from the start of the third-line
treatment to the end of 2009 were examined to identify the initiation of next systemic cancer …

… ; our data suggest that gefitinib and erlotinib might have … patients with EGFR-wt only, as
gefitinib and erlotinib are well known to induce a marked response and long PFS in patients with …

… However, the Japanese trial 4 and this meta-analysis reported similar risks for diarrhea with
both erlotinib and gefitinib. With more than 2500 patients from 16 randomized trials, the data …

… patients with different clinicopathological features or at different stages. We review the published
clinical trials that used gefitinib or erlotinib in … The OS data were not yet mature. The PFS …

… In this paper, we reviewed published data amassed worldwide for both erlotinib and gefitinib,
together with three randomized studies published with afatinib, to compare their toxicity …

… NCT01024413) comparing erlotinib with gefitinib for patients with exon 21 mutations. The …
Finally, the efficacy data for erlotinib and gefitinib indicated that a much larger sample size …

… data from our lung cancer patients to compare the benefits derived from erlotinib and gefitinib
… We subsequently analyzed tumor tissue from a subgroup of these patients for a pilot study …

… To the best of our knowledge, this is the first study worldwide to compare the efficacy of
erlotinib, gefitinib, and afatinib in patients with rare and common EGFR mutations. …